-
Cellebrite DI Ltd. (CLBT $15.90)
- $15.90 Cap: $3.97B
- View CLBT Profile
- View Questions on CLBT
Detailed Quote
Questions on this company?
Become a Member
Company Profile
{tplLang.businessdescription | toLang tLang}
{ profileData.description }
{tplLang.details | toLang tLang}
{tplLang.ceo | toLang tLang}
{profileData.profile.details.ceo}
{tplLang.employees | toLang tLang}
{profileData.profile.details.employees | numeraljs '0,0'}
{tplLang.issuetype | toLang tLang}
{profileData.profile.details.issuetype | asIssueType}
{tplLang.industryclassifications | toLang tLang}
{tplLang.sector | toLang tLang}
{profileData.profile.classification.sector}
{tplLang.industry | toLang tLang}
{profileData.profile.classification.industry}
{tplLang.toolname| toLang tLang}
There is no {tplLang.toolname| toLang tLang} currently available for
{data.symbolstring}.
Interactive Chart
Key Ratios
Earnings
Analyst Recommendations
5i Recent Questions
-
Cellebrite DI Ltd. (CLBT $15.90)
- $15.90 Cap: $3.97B
- View CLBT Profile
- View Questions on CLBT
Q: Happy Halloween 5i!
I’ve had Cellebrite for over a year now and it’s been largely flat floating between 16 and 20 bucks a share.
It seems to have great growth with high gross margins and reoccurring growth from its subscriptions.
However, investors don’t seem to be excited about it, could this be because of the reliance on the public service (high bureaucracy).
Or is it that they are not hugely profitable on a net income basis?
I know you folks like this company and I do too, just can’t figure out its lack of interest and am wondering if my money may work “better” in other stocks. (Though I know the value of patience can be very rewarding in investing so I’m trying to be disciplined!) :)
Can you tell me what the street expects on earnings this coming month?
Thanks folks - I hope you enjoy some Halloween treats with your coffee today!
I’ve had Cellebrite for over a year now and it’s been largely flat floating between 16 and 20 bucks a share.
It seems to have great growth with high gross margins and reoccurring growth from its subscriptions.
However, investors don’t seem to be excited about it, could this be because of the reliance on the public service (high bureaucracy).
Or is it that they are not hugely profitable on a net income basis?
I know you folks like this company and I do too, just can’t figure out its lack of interest and am wondering if my money may work “better” in other stocks. (Though I know the value of patience can be very rewarding in investing so I’m trying to be disciplined!) :)
Can you tell me what the street expects on earnings this coming month?
Thanks folks - I hope you enjoy some Halloween treats with your coffee today!
-
CECO Environmental Corp. (CECO $53.63)
- $53.63 P/E (TTM): 34.43X Cap: $1.85B
- View CECO Profile
- View Questions on CECO
-
Genius Sports Limited (GENI $11.25)
- $11.25 Cap: $2.65B
- View GENI Profile
- View Questions on GENI
-
Cellebrite DI Ltd. (CLBT $15.90)
- $15.90 Cap: $3.97B
- View CLBT Profile
- View Questions on CLBT
-
BlackSky Technology Inc. Class A (BKSY $18.73)
- $18.73 Cap: $724M
- View BKSY Profile
- View Questions on BKSY
-
Sportradar Group AG (SRAD $25.58)
- $25.58 Cap: $7.81B
- View SRAD Profile
- View Questions on SRAD
-
Karman Holdings Inc. (KRMN $84.70)
- $84.70 P/E (TTM): 1053.0X Cap: $11.51B
- View KRMN Profile
- View Questions on KRMN
-
Limbach Holdings Inc. (LMB $90.80)
- $90.80 P/E (TTM): 32.36X Cap: $1.09B
- View LMB Profile
- View Questions on LMB
Q: Please rank from best to worst at current purchase prices (for growth). Please also indicate if they would be a buy, sell or hold based on Thursday's prices.
-
Cellebrite DI Ltd. (CLBT $15.90)
- $15.90 Cap: $3.97B
- View CLBT Profile
- View Questions on CLBT
Q: CLBT has been on an improving trend for the last month or so. Any news to explain this? Do you still see the company as a favourable investment, and if so, why? Where do you see the share price going from here? Thank you for your excellent service
Insiders
Share Information
SEC Filings
News and Media